BNED vs RCKY

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no Altman Z-Score available, leaving bankruptcy risk unconfirmed but concerning given high leverage. Despite a low current P/E of 12.89 compared to sector average of 53.76, the negative forward P/E (-0.25) and collapsing earnings growth (-62% YoY) signal deteriorating profitability. The stock trades above the Graham Number of $11.53 but well above the intrinsic value of $4.97, suggesting overvaluation on a conservative basis. Persistent negative earnings surprises, declining ROE, and weak insider sentiment (40/100) further undermine confidence in a near-term turnaround.

RCKY demonstrates stable financial health with a Piotroski F-Score of 6/9 and a very strong current ratio of 2.82. The stock is currently trading at a discount to its Graham Number ($47.30) and significantly below its growth-based intrinsic value ($87.32). While technical trends (10/100) and insider sentiment (30/100) are currently bearish, the fundamental valuation—characterized by a low P/E of 14.83 relative to the sector average of 35.93—suggests a strong value opportunity. Strong earnings growth (34.4% YoY) and consistent estimate beats further support a bullish long-term outlook.